Medical release archive

Risk of repeat heart attack twice as likely from occlusions in arteries that did not cause initial event

New data show benefit of Tagrisso in patients with EGFR-mutated non-small cell lung cancer and central nervous system metastases

New England Journal of Medicine publishes results of Phase III FLAURA trial in the 1st-line treatment of EGFR-mutated non-small cell lung cancer

Faslodex (fulvestrant) receives EU approval for the treatment of hormone receptor-positive advanced breast cancer in combination with palbociclib

ZS-9 (sodium zirconium cyclosilicate) Phase III long-term safety and efficacy data presented at ASN Kidney Week 2017

AstraZeneca and Chi-Med’s savolitinib shows encouraging clinical activity in EGFR mutation-positive lung cancer with MET-amplification

Forxiga DEPICT-1 trial demonstrates improved glycaemic control without increasing hypoglycaemia, lowered weight and total daily insulin dose in patients with type-1 diabetes

AstraZeneca presents new evidence on Symbicort (budesonide/formoterol) in COPD patients at risk of exacerbation

New data supports long-term efficacy of ticagrelor in patients up to five years following a heart attack

AstraZeneca presents Tagrisso (osimertinib) data in patients with EGFR T790M-mutation positive lung cancer and central nervous system metastases